One patient with four additional mutations, including two co-occurrent variants in the DNMT3A gene, mutation in the TP53 gene and U2AF1 gene, transformed from ET to MF and then from MF to AML. This evidence concerns the gene U2AF1 and acute myeloid leukemia.